February 23, 2026
STOCKHOLM — Patients with moderately to severely active ulcerative colitis (UC) treated with the investigational, once-daily, oral obefazimod (Abivax, France) reported clinically meaningful improvements in disease-specific […]
February 20, 2026
STOCKHOLM — Certain occupations, particularly skilled trades involving pollutant exposure and physically demanding work, were associated with a higher risk of inflammatory bowel disease (IBD), according […]
February 20, 2026
TOPLINE: Among patients with metabolic dysfunction-associated steatotic liver disease (MASLD), bariatric surgery was associated with early significant reductions in the prevalence of MASLD and hepatic steatosis […]
February 20, 2026
TOPLINE: Among young adults with irritable bowel syndrome (IBS), 29.1% also reported having nonceliac gluten sensitivity. Those with both conditions more often had symptoms beyond the […]
February 19, 2026
TOPLINE: A narrative review reported that GLP-1s in adults with obesity and/or type 2 diabetes (T2D) were linked to an increased risk for nutritional deficiencies — […]
February 19, 2026
The recently updated practice guideline from the American Gastroenterological Association (AGA) on the surveillance of Barrett’s esophagus (BE) is an attempt to strike a balance between […]
February 19, 2026
TOPLINE: Statin use in patients with primary biliary cholangitis (PBC) was associated with reduced risks for hepatic decompensation and major adverse liver outcomes. METHODOLOGY: Previous studies […]
February 18, 2026
One of the hot products showcased at the recent Consumer Electronic Show (CES) was the smart toilet. In its analyst report on CES highlights, research firm […]
February 18, 2026
TOPLINE: Among patients with severe ulcerative colitis (UC) who had not previously received biologic treatments, infliximab or upadacitinib produced the fastest and largest symptom improvements, both […]